User talk:97.92.111.70

Revision of biography originally written by a financially biased competitor
Vera S. Byers, MD, PhD, received her PhD in Immunology from UCLA, her MD from UCSF and is Board Certified in Internal Medicine. She completed a postdoctoral fellowship in Clinical Immunology at UCSF, and a fellowship in protein chemistry from Abbott Laboratory. She was on the adjunct faculty of the Department of Dermatology at UCSF for 34 years, from 1974 to 2008. In 1983 she joined XOMA corporation as Consulting Medical Director, and University of Nottingham as Special Lecturer. While in Nottingham she co-invented the first monoclonal antibody to be used in humans, 791-36. ( M. J. Embleton, B. Gunn, V. S. Byers and R. W. Baldwin, Antitumor Reactions of Monoclonal Antibody Against A Human Osteogenic Sarcoma Cell Line, Br. J. Cancer (1981) 43, 582) and continued to use other monoclonal antibodies in clinical trials, specifically graft vs. host disease and a series of autoimmune diseases. She then turned to consulting, running clinical trials in a variety of trials including cancer treatments using biologics. She continues to work as President of Immunology Inc. Nevada. As a consultant she was an expert medical witness for multiple plaintiff cases involving exposure to environmental toxins. One of these, described in “A Civil Action” was the first leukemia cluster to be identified, and in which an environmental cause (Trichloroethylene) was identified. (Byers, V.S., Levin, A.S., Ozonoff, D.M., and Baldwin, R.W.: Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent- contaminated domestic water supply and a high incidence of leukaemia. Cancer Immunol. Immunother. 27:77, 1988). She served on NIH review boards for many years, evaluating grants for cancer therapy. She has published over 140 peer reviewed medical journal articles. She was in medical practice in Allergy/Immunology for 25 years and headed the largest HIV clinic in California (Positive Action Health Care from 1988-1991 and designed and ran the clinical trials in HIV which formed the basis for the FDA “Fast Track” drug approval plan. With her vast knowledge in internal medicine and basic immunology she has served as Petitioners’ expert witness in the Federal Vaccine Claims Court where she occasionally receives ridicule from politically motivated lawyers who have no training in immunology, so called “Special Masters” and from paid consultants with little or no training in basic immunology and whose interests are more centered on financial remuneration than biological facts.